The Value of Full-targeted Pathogen Capture Metagenomics Next Generation Sequencing in Etiological Diagnosis of Sepsis
NCT ID: NCT05540808
Last Updated: 2023-02-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
86 participants
OBSERVATIONAL
2023-02-10
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Regulatory Network and Diagnostic Value of Key Autophagy-related Genes in Sepsis
NCT05524376
Genomics in Infection and Sepsis to Predict Organ Dysfunction and Outcomes in Sepsis
NCT04199962
Nasal and Gut Microbiota Combined Clinical Events Predicts the Prognosis of Septic Patients
NCT05143736
Identification Sepsis Related Single Nucleotide Polymorphism (SNP) by Whole Exome Sequencing
NCT01920217
Next-Generation Sequencing Diagnostics of Bacteremia in Sepsis
NCT03356249
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with sepsis
Exclusion Criteria
* Discharge diagnosis without clear etiology
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shenzhen Second People's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ying Li
Role: STUDY_CHAIR
Shenzhen Second People's Hospital
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20223357008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.